BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38418121)

  • 1. The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
    In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy.
    Liu J; Wang Z; Liu G; Liu Z; Lu H; Ji S
    Ann Med; 2023; 55(2):2242254. PubMed ID: 37552770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer.
    Otani K; Aoyama T; Maezawa Y; Hashimoto I; Kamiya N; Kato A; Numata M; Kawahara S; Tamagawa A; Nakazono M; Tamagawa H; Segami K; Kazama K; Sawazaki S; Yukawa N; Saito A; Rino Y
    In Vivo; 2024; 38(2):897-903. PubMed ID: 38418135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study.
    Li Q; Cong R; Wang Y; Kong F; Ma J; Wu Q; Ma X
    Gynecol Oncol; 2021 Jan; 160(1):91-98. PubMed ID: 33081984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score.
    Galizia G; Auricchio A; de Vita F; Cardella F; Mabilia A; Basile N; Orditura M; Lieto E
    Ann Ital Chir; 2019; 90():404-416. PubMed ID: 31814602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer.
    Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Takahashi K; Fujikawa H; Aoyama T; Numata M; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
    Ann Surg Oncol; 2021 Aug; 28(8):4530-4539. PubMed ID: 33423121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Xie YM; Lu W; Cheng J; Dai M; Liu SY; Wang DD; Fu TW; Ye TW; Liu JW; Zhang CW; Huang DS; Liang L
    J Hepatocell Carcinoma; 2023; 10():1423-1433. PubMed ID: 37691971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis.
    Sugimoto A; Fukuoka T; Shibutani M; Kasashima H; Kitayama K; Ohira M; Maeda K
    BMC Gastroenterol; 2023 Mar; 23(1):88. PubMed ID: 36966294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which Nutritional Scoring System Is More Suitable for Evaluating the Short- or Long-Term Prognosis of Patients with Gastric Cancer Who Underwent Radical Gastrectomy?
    Lin JX; Lin LZ; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
    J Gastrointest Surg; 2020 Sep; 24(9):1969-1977. PubMed ID: 31452078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma.
    Jin J; Wang H; Peng F; Wang X; Wang M; Zhu F; Xiong G; Qin R
    Hepatobiliary Surg Nutr; 2021 Dec; 10(6):825-838. PubMed ID: 35004948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection.
    Fukuda N; Sugiyama Y; Wada J
    World J Gastroenterol; 2011 Mar; 17(9):1180-4. PubMed ID: 21448423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative Prolonged Inflammatory Response as a Poor Prognostic Factor After Curative Resection for Gastric Cancer.
    Okumura Y; Hiki N; Kumagai K; Ida S; Nunobe S; Ohashi M; Sano T
    World J Surg; 2017 Oct; 41(10):2611-2618. PubMed ID: 28451762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Albumin-Bilirubin Score Is a Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
    Ju M; Aoyama T; Komori K; Tamagawa H; Tamagawa A; Maezawa Y; Morita J; Onodera A; Endo K; Hashimoto I; Kano K; Hara K; Cho H; Nakazono M; Segami K; Ishiguro T; Onuma S; Oshima T; Yukawa N; Rino Y
    Anticancer Res; 2022 Aug; 42(8):3929-3935. PubMed ID: 35896262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Nakazano M; Nagasawa S; Hara K; Komori K; Tamagawa H; Maezawa Y; Segami K; Kano K; Ogata T; Yukawa N; Rino Y; Oshima T
    In Vivo; 2022; 36(1):482-489. PubMed ID: 34972752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Kazama K; Numata M; Kamiya N; Tamagawa H; Sawazaki S; Kawahara S; Komori K; Tamagawa A; Cho H; Morita J; Otani K; Kato A; Tanabe M; Oshima T; Yukawa N; Saito A; Rino Y
    In Vivo; 2023; 37(6):2696-2703. PubMed ID: 37905661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic inflammation score as a preoperative prognostic factor for patients with pT2-T4 resectable gastric cancer: a retrospective study.
    Matsumoto T; Ohki S; Kaneta A; Matsuishi A; Maruyama Y; Yamada L; Tada T; Hanayama H; Watanabe Y; Hayase S; Okayama H; Sakamoto W; Momma T; Saze Z; Kono K
    BMC Surg; 2023 Jan; 23(1):8. PubMed ID: 36635689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.
    Aoyama T; Komori K; Nakazano M; Hara K; Tamagawa H; Kazama K; Hashimoto I; Yamada T; Maezawa Y; Segami K; Kano K; Nagasawa S; Yukawa N; Rino Y; Ogata T; Oshima T
    In Vivo; 2022; 36(2):942-948. PubMed ID: 35241553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Impact of Change in the C-Reactive Protein/Albumin Ratio in Gastric Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Maezawa Y; Hashimoto I; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kawahara S; Cho H; Morita J; Segami K; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    J Gastrointest Cancer; 2024 Mar; 55(1):383-390. PubMed ID: 37784000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kamiya N; Kato A; Yamada T; Nagasawa S; Kawahara S; Cho H; Morita J; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    Anticancer Res; 2023 Nov; 43(11):5181-5187. PubMed ID: 37909998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Naples prognostic score in esophagus cancer: Prognostic and beyond.
    Demir M; Demircan NC
    Bull Cancer; 2023 Oct; 110(10):1027-1040. PubMed ID: 37516650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.